Entera Bio ENTX
NASDAQ ENTX
$2.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Total Debt (2017 - 2026)

Updated

Entera Bio's Total Debt was $284,000 in Q2 2026, down 45.8% from $524,000 a year earlier and down 49.9% from the prior quarter.

Analysis

Entera Bio (ENTX) Total Debt (2017 - 2026) Analysis & Trends

At the end of FY2025, Total Debt at Entera Bio came in at $393,000.

  • Per Business Quant data, ENTX's Total Debt in the three quarters before Q2 2026 was $567,000 (Q1 2026), $393,000 (Q4 2025) and $527,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Entera Bio 132.59 Mn 101.46 Mn - 284,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 284,000.00
Mar 31, 2026 567,000.00
Dec 31, 2025 393,000.00
Sep 30, 2025 527,000.00
Jun 30, 2025 524,000.00
Mar 31, 2025 515,000.00
Dec 31, 2017 3.89 Mn
API Access

Entera Bio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ENTX&period=max&api_key=YOUR_API_KEY